04/07/2012 10:37:00

UPDATE: Russia Net Capital Outflow Jan-June at $43.4 Billion

Related content

(Adds quarterly breakdown and background)

MOSCOW--Russia saw a net $43.4 billion in capital outflow in the first six months of the year, the central bank said Wednesday.

Capital outflow for the first quarter amounted to $33.9 billion, adjusted downwards from an earlier figure of $35.1 billion. Outflows shrank in the second quarter to $9.5 billion, the data showed.

Last month, the central bank said that outflows for January to June stood at $46.5 billion.

The central bank says capital flight is a twofold problem: Russian investors are boosting foreign assets and foreign investors are fleeing emerging markets amid debt worries in the euro area, one of Russia's main trading partners.

Write to Ira Iosebashvili at ira.iosebashvili@dowjones.com

(END) Dow Jones Newswires

July 04, 2012 05:37 ET (09:37 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

Tech Companies Send Criticism Along With NSA-Related Data -- Update

04/02/2014 00:06:00
By Danny Yadron Technology companies including Google Inc. and Microsoft Corp. released new figures on the amount of data requests they received from U.S. ..

U.S. Hot Stocks: Hot Stocks to Watch

03/02/2014 14:07:00
Among the companies with shares expected to actively trade in Monday's session is Herbalife Ltd. (HLF). Herbalife Ltd. (HLF) raised its fourth-quarter outl..

Pfizer Study Meets Primary Endpoints

03/02/2014 13:05:00
Pfizer Inc. (PFE) said Monday that a Phase 2 trial of its advanced breast cancer treatment met its primary endpoint. Pfizer said a study comparing the effec..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Heijmans starts construction of 338 homes in Leiden
2
Medtronic Receives FDA Approval for PRESTIGE® LP Cervical Disc System
3
Zealand and Boehringer Ingelheim sign second collaboration agreement to advance novel peptide medicines
4
ALSTOM SA : Alstom to supply major equipment and maintenance package for Iberdrola's Monterrey III power plant
5
Alcon's Simbrinza® approved in the EU to treat patients living with glaucoma, a chronic sight-threatening eye disease

Related stock quotes

Euroinvestor around the globe: Euroinvestor.dk | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
28 July 2014 23:30:48
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20140723.1 - EUROWEB5 - 2014-07-29 00:30:48 - 2014-07-28 23:30:48 - 1000 - Website: OKAY